Physician profile
Perry J Lucente
NPI 1003973538
$1,843.79
in general payments reported to CMS, 2019-2025
17 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $76.87 · 2021: $269 · 2022: $244 · 2023: $450 · 2024: $388 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $409.34 | 2020-2025 | Total30, Precision7, Precision 1 |
| Bausch & Lomb Americas INC. | $242.21 | 2022-2025 | Infuse, Miebo |
| Lkc Technologies, INC. | $203.75 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $179.16 | 2020-2021 | |
| Oyster Point Pharma, INC. | $150.49 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $124.73 | 2025 | Idosetr |
| Sun Pharmaceutical Industries INC. | $113.74 | 2022-2023 | Cequa |
| Allergan, INC. | $110.95 | 2021 | |
| Optovue, INC. | $96.61 | 2019 | |
| Biotissue Holdings INC. | $38.67 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $35.89 | 2022-2023 | Acuvue |
| Coopervision INC. | $35.13 | 2019 | |
| Sight Sciences, INC. | $29.70 | 2022 | |
| Dompe US, INC. | $20.87 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $20.71 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $17.48 | 2024 | Spectacle Lenses, Contact Lens |
| Abbvie INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Lucente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.